BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

31 related articles for article (PubMed ID: 1137662)

  • 1. Bioavailability of drugs: the digoxin dilemma.
    Greenblatt DJ; Smith TW; Koch-Weser J
    Clin Pharmacokinet; 1976; 1(1):36-51. PubMed ID: 797491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A nomogram for digoxin therapy.
    Jelliffe RW; Brooker G
    Am J Med; 1974 Jul; 57(1):63-8. PubMed ID: 4600984
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment with digoxin and measurement of serum digoxin levels after myocardial infarction.
    Sharpe DN; Norris RM; McL White B
    Br Heart J; 1975 May; 37(5):530-3. PubMed ID: 1137662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of intravenous digoxin on the occurrence of ventricular tachyarrhythmias in acute myocardial infarction in man.
    Reicansky I; Conradson TB; Holmberg S; Rydén L; Waldenström A; Wennerblom B
    Am Heart J; 1976 Jun; 91(6):705-11. PubMed ID: 775954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-response relation between therapeutic levels of serum digoxin and systolic time intervals.
    Hoeschen RJ; Cuddy TE
    Am J Cardiol; 1975 Apr; 35(4):469-72. PubMed ID: 1119396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum digoxin by radioimmunoassay.
    Hoeschen RJ; Proveda V
    Can Med Assoc J; 1971 Jul; 105(2):170-3. PubMed ID: 5104858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of pharmacokinetics and dosage in digoxin maintenance therapy. A retrospective analysis of serum digoxin levels.
    Joubert PH; Müller FO; Pansegrouw DF
    S Afr Med J; 1974 May; 48(21):907-9. PubMed ID: 4834608
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacokinetics of digoxin in patients with acute myocardial infarction.
    Korhonen UR; Jounela AJ; Pakarinen AJ; Pentikäinen PJ; Takkunen JT
    Am J Cardiol; 1979 Nov; 44(6):1190-4. PubMed ID: 495514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of strophanthus on coronary blood flow and cardiac oxygen consumption of normal and failing human hearts.
    BING RJ; MARAIST FM; DAMMANN JF; DRAPER A; HEIMBECKER R; DALEY R; GERARD R; CALAZEL P
    Circulation; 1950 Oct; 2(4):513-6. PubMed ID: 14772978
    [No Abstract]   [Full Text] [Related]  

  • 10. STUDIES FOLLOWING INTRAMUSCULAR TRITIATED DIGOXIN IN HUMAN SUBJECTS.
    DOHERTY JE; PERKINS WH
    Am J Cardiol; 1965 Feb; 15():170-4. PubMed ID: 14254809
    [No Abstract]   [Full Text] [Related]  

  • 11. EFFECT OF ACETYL STROPHANTHIDIN THERAPY ON CARDIAC DYNAMICS, OXYGEN CONSUMPTION AND EFFICIENCY IN THE ISOLATED HEART WITH AND WITHOUT HYPOXIA.
    SARNOFF SJ; GILMORE JP; WALLACE AG; SKINNER NS; MITCHELL JH; DAGGETT WM
    Am J Med; 1964 Jul; 37():3-13. PubMed ID: 14181148
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on myocardial metabolism. V. The effects of lanatoside-C on the metabolism of the human heart.
    BLAIN JM; EDDLEMAN EE; SIEGEL A; BING RJ
    J Clin Invest; 1956 Mar; 35(3):314-21. PubMed ID: 13295395
    [No Abstract]   [Full Text] [Related]  

  • 13. Velocity of contraction as a determinant of myocardial oxygen consumption.
    Sonnenblick EH; Ross J; Covell JW; Kaiser GA; Braunwald E
    Am J Physiol; 1965 Nov; 209(5):919-27. PubMed ID: 5849492
    [No Abstract]   [Full Text] [Related]  

  • 14. Digitalis and experimental myocardial infarction.
    Morris JJ; Taft CV; Whalen RE; McIntosh HD
    Am Heart J; 1969 Mar; 77(3):342-55. PubMed ID: 5766720
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.